CANDICE HOLDER: Open Payments
NPI 1376976530 · ROCKFORD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$563 in 26 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $55 · 2025 $563
Food & beverage: $563
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $176 |
| Otsuka America Pharmaceutical, Inc. | 4 | $103 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $95 |
| Teva Pharmaceuticals USA, Inc. | 3 | $63 |
| Collegium Pharmaceutical, Inc. | 2 | $42 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Alkermes, Inc. | 1 | $20 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
Products named: VRAYLAR, REXULTI, CAPLYTA, AUSTEDO XR, Jornay PM, Auvelity, TRINTELLIX, ARISTADA.
Industry payments across IL — which companies pay providers there.
